Bio-Rad Laboratories, Inc. (BIO.B)
NYSE: BIO.B · Real-Time Price · USD
334.85
0.00 (0.00%)
Oct 3, 2024, 8:31 AM EST - Market closed
Bio-Rad Laboratories Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -778.69 | -637.32 | -3,628 | 4,254 | 3,814 | 1,759 | Upgrade
|
| Depreciation & Amortization | 149.6 | 145.9 | 137.3 | 137.6 | 175.7 | 134.2 | Upgrade
|
| Loss (Gain) From Sale of Assets | -2.5 | -2.5 | -1.4 | - | -11.7 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 29.5 | - | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 1,356 | 1,252 | 5,206 | -4,925 | -4,491 | -2,025 | Upgrade
|
| Stock-Based Compensation | 62.1 | 61.3 | 60.9 | 51.2 | 41.6 | 35.6 | Upgrade
|
| Other Operating Activities | 8.89 | -11.98 | 22.14 | 8.74 | -32.53 | -1.28 | Upgrade
|
| Change in Accounts Receivable | 5.4 | 11.4 | -87.4 | -20.4 | -15 | 1.6 | Upgrade
|
| Change in Inventory | -0.6 | -46.3 | -158.8 | 46.1 | -52.1 | 24.2 | Upgrade
|
| Change in Accounts Payable | -3.8 | -51.8 | -94.2 | 69.9 | 124.7 | 10.6 | Upgrade
|
| Change in Income Taxes | -55.9 | -21.3 | -1.2 | -28.8 | 39 | -4.2 | Upgrade
|
| Change in Other Net Operating Assets | -24.4 | -2.2 | -26.8 | -8.6 | 10.9 | 73.5 | Upgrade
|
| Operating Cash Flow | 412 | 374.9 | 194.4 | 669.5 | 585 | 457.9 | Upgrade
|
| Operating Cash Flow Growth | 10.30% | 92.85% | -70.96% | 14.44% | 27.76% | 60.39% | Upgrade
|
| Capital Expenditures | -164.93 | -156.68 | -112.78 | -133.75 | -108.56 | -98.53 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.26 | 0.21 | 0.16 | 0.05 | 0.07 | 0.13 | Upgrade
|
| Cash Acquisitions | - | - | -100.75 | -125.52 | -96.66 | -79.39 | Upgrade
|
| Divestitures | 2.5 | 2.5 | 1.36 | - | 12.24 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -23.41 | - | -1.38 | - | 3.41 | 8.82 | Upgrade
|
| Investment in Securities | 128.13 | 174.18 | -994.21 | -84.73 | 119.6 | -39.92 | Upgrade
|
| Investing Cash Flow | -57.46 | 20.21 | -1,208 | -797.38 | -69.89 | -208.89 | Upgrade
|
| Long-Term Debt Issued | - | - | 1,186 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -0.47 | -0.51 | -3.02 | -426.94 | -0.64 | Upgrade
|
| Net Debt Issued (Repaid) | -0.48 | -0.47 | 1,186 | -3.02 | -426.94 | -0.64 | Upgrade
|
| Issuance of Common Stock | 19.61 | 18.48 | 17.56 | 20.63 | 20.2 | 16.94 | Upgrade
|
| Repurchase of Common Stock | -411.68 | -443.66 | -229.65 | -72.48 | -112.93 | -36.1 | Upgrade
|
| Other Financing Activities | -0.62 | - | -0.05 | -0.56 | -3.37 | -2.96 | Upgrade
|
| Financing Cash Flow | -393.17 | -425.65 | 973.58 | -55.43 | -523.04 | -22.76 | Upgrade
|
| Foreign Exchange Rate Adjustments | -7.59 | 0.32 | 2.98 | -12.64 | 12.43 | 2.24 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | 0.1 | 0.04 | 0.05 | -0.04 | -0.03 | - | Upgrade
|
| Net Cash Flow | -46.13 | -30.18 | -36.59 | -195.98 | 4.46 | 228.49 | Upgrade
|
| Free Cash Flow | 247.07 | 218.22 | 81.62 | 535.75 | 476.44 | 359.37 | Upgrade
|
| Free Cash Flow Growth | 10.16% | 167.37% | -84.77% | 12.45% | 32.58% | 130.85% | Upgrade
|
| Free Cash Flow Margin | 9.58% | 8.17% | 2.91% | 18.33% | 18.72% | 15.55% | Upgrade
|
| Free Cash Flow Per Share | 8.70 | 7.47 | 2.74 | 17.74 | 15.80 | 11.91 | Upgrade
|
| Cash Income Tax Paid | 164.34 | 129.59 | 158.26 | 134.68 | 65.24 | 45.08 | Upgrade
|
| Levered Free Cash Flow | 91.24 | 124.32 | 5.63 | 485.98 | 427.88 | 315.82 | Upgrade
|
| Unlevered Free Cash Flow | 121.92 | 155.22 | 29.45 | 486.95 | 441.54 | 330.45 | Upgrade
|
| Change in Net Working Capital | 110.12 | 123.86 | 358.85 | -78.94 | -66.07 | -106.83 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.